Home / Share Price Target / Indous
Indo US Bio-Tech Share Price Target 2024, 2025, 2026 to 2039 With Charts
Indo US Bio-Tech Limited | |||
 | Symbol: INDOUS | ||
| Price: ₹249.3 | |||
| Exchange: BSE | |||
| -> | |||
Show Table of Contents
Table of Contents
- 0.1: Indo US Bio-Tech Financial Performance
- 0.1.1: Is Indo US Bio-Tech A Good Buy For Long Term?
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Indo US Bio-Tech Share Price Target For 2024
- 1.1.1: Indo US Bio-Tech Share Price Target Table For 2024
- 1.1.2: Summary: Indo US Bio-Tech Share Price Prediction For 2024
- 1.2: Indo US Bio-Tech Share Price Target For 2025
- 1.2.1: Indo US Bio-Tech Share Price Target Table For 2025
- 1.2.2: Summary: Indo US Bio-Tech Share Price Prediction For 2025
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Indo US Bio-Tech Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 2.2: Indo US Bio-Tech Share Price Target Table From 2024, 2025, 2026 to 2039
- 3: Indo US Bio-Tech Past Performance
Indo US Bio-Tech Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 497.18 Crore | Market valuation of Indo US Bio-Tech's shares. |
| Revenue (TTM) | 78.41 Crore | Total revenue generated by Indo US Bio-Tech over the past twelve months. |
| Net Income (TTM) | +9.04 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 14.23% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 11.53% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +29.1% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | +33.5% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 22.82 | Company's total debt divided by total shareholder equity. |
| Total Debt | 14.32 Crore | Sum of Indo US Bio-Tech's current & long-term financial obligations. |
| Total Cash | 1.09 Crore | Total amount of liquid funds available to Indo US Bio-Tech. |
| Beta | -0.24 | Beta is less than 1 indicating that the Indo US Bio-Tech's price is less volatile than the market. |
Is Indo US Bio-Tech A Good Buy For Long Term?
Indo US Bio-Tech, a small-cap stock with a market capitalization of ₹483.55 crore, shows mixed signals for long-term investment. While its impressive 3-year return of 414.40% and recent quarterly revenue growth of 29.1% are positive, the relatively low profit margin of 11.53% and a significant debt of ₹14.32 crore (against a cash balance of only ₹1.09 crore) raise concerns. The 5-year return of 0.00% also warrants caution. Therefore, it's currently an average buy, requiring further due diligence before considering a long-term investment.
To predict the Indo US Bio-Tech's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Indo US Bio-Tech Share Price Target For 2024
The line chart displays the monthly closing prices of Indo US Bio-Tech with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Indo US Bio-Tech shares in 2024, see the table below.
Indo US Bio-Tech Share Price Target Table For 2024
| Indo US Bio-Tech's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 257.85 (+3.42%) | Price Action: Feb 2024 High |
| 2024 Target 2 | 255.12 (+2.33%) | Custom Fibonacci Extension Lvl 50% |
| 2024 Target 1 | 251.95 (+1.06%) | Price Action: 23 Oct 2024 High |
| Current Price | 249.30 | Indo US Bio-Tech's 1 share price as of Fri 22 Nov 2024 |
| Stop Loss 1 | 248.41 (-0.36%) | Fibonacci Retracement Level 98.6% |
| Stop Loss 2 | 244.97 (-1.74%) | Fibonacci Retracement Extended 28.2% |
| Stop Loss 3 | 242.25 (-2.83%) | Price Action: Jan 2023 High |
Summary: Indo US Bio-Tech Share Price Prediction For 2024
In summary, Indo US Bio-Tech has surged by ₹9.30, achieving a notable +3.88% increase from 1st January 2024 to 22 Nov 2024. Our analysis of Indo US Bio-Tech for 2024 predicts an additional rise of 1.06% to 3.42% by the end of 2024 with three potential targets T1: 251.95, T2: 255.12, T3: 257.85. Stop Loss at SL1: 248.41, SL2: 244.97, SL3: 242.25.
Indo US Bio-Tech has a 52-week high of ₹349.79, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹180.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Indo US Bio-Tech.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Indo US Bio-Tech Share Price Target For 2025
The line chart displays the monthly closing prices of Indo US Bio-Tech with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Indo US Bio-Tech shares in 2025, see the table below.
Indo US Bio-Tech Share Price Target Table For 2025
| Indo US Bio-Tech's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 353.04 (+41.61%) | Fibonacci Extension Level 123.6% |
| 2025 Target 2 | 343.56 (+37.8%) | Price Action: Chart |
| 2025 Target 1 | 340.16 (+36.44%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 249.30 | Indo US Bio-Tech's 1 share price as of Fri 22 Nov 2024 |
| Stop Loss 1 | 228.00 (-8.55%) | Price Action: Feb 2024 Low |
| Stop Loss 2 | 225.00 (-9.75%) | Price Action: Jul 2024 High |
| Stop Loss 3 | 220.95 (-11.38%) | Price Action: Chart |
Summary: Indo US Bio-Tech Share Price Prediction For 2025
In summary, Indo US Bio-Tech has surged by ₹9.30, achieving a notable +3.88% increase from 1st January 2024 to 22 Nov 2024. Our analysis of Indo US Bio-Tech for 2025 predicts an additional rise of 36.44% to 41.61% by the end of 2025 with three potential targets T1: 340.16, T2: 343.56, T3: 353.04. Stop Loss at SL1: 228.00, SL2: 225.00, SL3: 220.95.
Indo US Bio-Tech has a All-Time high of ₹570.40, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹180.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Indo US Bio-Tech, we have created a specific page for that check here: Indo US Bio-Tech Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Indo US Bio-Tech Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Indo US Bio-Tech share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 11.72% over the next 15 years.
For complete year by year Indo US Bio-Tech long term share price target from 2024, 2025 to 2039 check the below table.
Indo US Bio-Tech Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Indo US Bio-Tech Target | YoY Change % |
|---|---|---|
| 2024 | ₹249.3 | [Current Price] |
| 2024 | ₹278.39 | 11.66% |
| 2025 | ₹356.04 | 27.89% |
| 2026 | ₹426.67 | 19.83% |
| 2027 | ₹527.86 | 23.71% |
| 2028 | ₹597.29 | 13.15% |
| 2029 | ₹641.74 | 7.44% |
| 2030 | ₹724.55 | 12.9% |
| 2031 | ₹792.54 | 9.38% |
| 2032 | ₹914.24 | 15.35% |
| 2033 | ₹978.66 | 7.04% |
| 2034 | ₹1,005.08 | 2.69% |
| 2035 | ₹1,093.05 | 8.75% |
| 2036 | ₹1,158.41 | 5.97% |
| 2037 | ₹1,300.61 | 12.27% |
| 2038 | ₹1,360.03 | 4.56% |
| 2039 | ₹1,314.14 | -3.38% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Indo US Bio-Tech Past Performance
- In 2020, Indo US Bio-Tech opening price was ₹51
- As of Fri 22 Nov 2024 the price stands at ₹249.3.
- This represents a Compound Annual Growth Rate (CAGR) of 37.35%.
- In 4 years, an investment of 10,000 would have become ₹48,882.35.
As we wrap up, we hope you like our study on Indo US Bio-Tech share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
